Grifols, S.A.
- GRFS
- NASDAQ
- Drug manufacturers
- Plasma-Derived Therapeutics
- Blood Products
$7.64
Today +1.33%Quote Oct 16, 2026, 08:00 PM UTC
+3.24%over the last month
Max drawdown −4.7%From 1-month high 0.0%3 months +0.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$5.20B
Approximate share count
Next earnings
Nov 10
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$7.59
0.6% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about GRFSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Drug manufacturers
Employees
25,258
Founded
1940